Details for Patent: 11,771,624
Which drugs does patent 11,771,624 protect, and when does it expire?
Patent 11,771,624 protects POSIMIR and is included in one NDA.
This patent has seven patent family members in seven countries.
Summary for Patent: 11,771,624
| Title: | Sustained release drug delivery systems with reduced impurities and related methods |
| Abstract: | The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided. |
| Inventor(s): | Andrew R. Miksztal, Judy Joice, Susan Autio, Mark P. Davis |
| Assignee: | Medicis Pharmaceutical Corp |
| Application Number: | US17/581,665 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,771,624
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innocoll | POSIMIR | bupivacaine | SOLUTION;INFILTRATION | 204803-001 | Feb 1, 2021 | DISCN | Yes | No | 11,771,624 | ⤷ Start Trial | TO PRODUCE POST-SURGICAL ANALGESIA | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,771,624
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Brazil | 112022013784 | ⤷ Start Trial | |||
| Canada | 3167217 | ⤷ Start Trial | |||
| China | 115666621 | ⤷ Start Trial | |||
| European Patent Office | 4090353 | ⤷ Start Trial | |||
| Japan | 2023515918 | ⤷ Start Trial | |||
| South Korea | 20220140711 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
